NCT04216576进行中（未招募）不适用
Oral Self-Management of Palbociclib (Ibrance®) Using Mobile Technology
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 45
- 试验地点
- 13
- 主要终点
- Accuracy rate of medication self-administration
研究概览
简要总结
The purpose of this study is to find out whether it is feasible (acceptable to participants) to use a smartphone app to send text message reminders to take palbociclib, and whether these reminders are effective at helping people remember to take palbociclib according to the treatment schedule.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Patients with a breast cancer diagnosis who are initiating therapy on palbociclib (Ibrance)
- •>/= 18 years of age
- •Able to speak, read and write English
- •Willingness and ability to send and receive text messages with intervention app
- •Own a mobile telephone "smartphone" with text messaging capabilities. Only iPhone or Android operating systems support OhMD Application
- •Criteria applicable for both Control and Intervention groups
- •Flip-phones do not support OhMD Application and thus ineligible to participate
- •Initiation palbociclib (Ibrance) for the first time, either as monotherapy or in conjunction with other medication such as Lstrozole (Femara) or Fulvestrant (Faslodex)
排除标准
- •History of taking palbociclib (Ibrance)
- •Patients whose caregivers coordinate their health care
结局指标
主要结局
Accuracy rate of medication self-administration
时间窗: Up to 1 year
The effectiveness of a mobile technology intervention by calculating the proportion of the number of days that the participant accurately self-administers the medication divided by the number of days the medication should have been taken
次要结局
未报告次要终点
研究者
研究点 (13)
Loading locations...
相似试验
已完成
早期 1 期
Oral Administration of MB-102 Versus Dual Sugar Testing for Gut PermeabilityCrohn DiseaseNCT03962998MediBeacon22
进行中（未招募）
1 期
Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid TumorsSolid TumorsRhabdoid TumorMedulloblastomaDiffuse Intrinsic Pontine GliomaNeuroblastomaEwing SarcomaRhabdomyosarcomaNCT03709680Pfizer128
已完成
1 期
A Study to Evaluate the Safety, Tolerability, and Fecal Pharmacokinetics of BX002-A in Healthy AdultsHealthy VolunteersNCT04737876BiomX, Inc.18
进行中（未招募）
1 期
Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC)Metastatic Breast Cancer (MBC)NCT02605486Memorial Sloan Kettering Cancer Center46
已完成
不适用
A Study to Understand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other OrgansBreast CancerNCT06003114Pfizer472